To include your compound in the COVID-19 Resource Center, submit it here.

EchoGen Emulsion which uses PhaseShift technology to convert liquid emulsion into gas microbubbles in the bloodstream data

The Bothell, Wash., company announced Phase II results in 59 patients, showing significantly increased visualization of blood flow and tumors.

Read the full 207 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE